M Marcatti
Overview
Explore the profile of M Marcatti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farina F, Sannipoli D, Diral E, Mastaglio S, Oltolini C, DellAcqua R, et al.
J Infect
. 2024 Nov;
89(6):106347.
PMID: 39577492
No abstract available.
2.
Farina F, Ferla V, Marktel S, Clerici D, Mastaglio S, Perini T, et al.
Front Oncol
. 2022 Aug;
12:867301.
PMID: 35928865
Life expectancy of multiple myeloma (MM) patients has improved in last years due to the advent of anti-CD38 monoclonal antibodies in combination with immunomodulators and proteasome inhibitors. However, morbidity and...
3.
Spoladore R, Falasconi G, Marcatti M, Di Maio S, Fiore G, Slavich M, et al.
Expert Opin Pharmacother
. 2020 Oct;
22(4):469-481.
PMID: 33043721
Introduction: Amyloidosis is a group of progressive and devastating disorders resulting from extracellular deposition of misfolded proteins into tissues. When deposition of fibrils occurs in cardiac tissues, this systemic disease...
4.
Frenquelli M, Caridi N, Antonini E, Storti F, Vigano V, Gaviraghi M, et al.
Leukemia
. 2019 Jun;
34(1):257-270.
PMID: 31148590
Multiple myeloma is the second most frequent hematological cancer after lymphoma and remains an incurable disease. The pervasive support provided by the bone marrow microenvironment to myeloma cells is crucial...
5.
Crucitti L, Crocchiolo R, Toffalori C, Mazzi B, Greco R, Signori A, et al.
Leukemia
. 2014 Nov;
29(5):1143-52.
PMID: 25371177
Genomic loss of the mismatched human leukocyte antigen (HLA) is a recently described mechanism of leukemia immune escape and relapse after allogeneic hematopoietic stem cell transplantation (HSCT). Here we first...
6.
Greco R, Mancini N, Peccatori J, Cieri N, Vago L, Giglio F, et al.
Heart Lung Vessel
. 2014 Jul;
6(2):119-24.
PMID: 25024994
Diagnosis of invasive fungal infection remains challenging. Here we report a case of early diagnosis of invasive aspergillosis in a neutropenic patient affected by acute myeloid leukaemia, achieved through the...
7.
Peccatori J, Forcina A, Clerici D, Crocchiolo R, Vago L, Stanghellini M, et al.
Leukemia
. 2014 Jun;
29(2):396-405.
PMID: 24897508
Hematopoietic stem cell transplantation (HSCT) from human leukocyte antigen (HLA) haploidentical family donors is a promising therapeutic option for high-risk hematologic malignancies. Here we explored in 121 patients, mostly with...
8.
Diquattro M, De Francisci G, Bonaccorso R, Tagliavia A, Marcatti M, Palma B, et al.
Int J Lab Hematol
. 2013 May;
35(6):637-43.
PMID: 23702080
Introduction: Pathogen Inactivation allows to overcome microbial contamination and growth related to storage of platelets concentrates (PC) at room temperature. The aim of our study was to evaluate the platelet...
9.
Marcatti M, Mauri S, Tresoldi M, Sabbadini M, ViganoDAngelo S, Safa O, et al.
Thromb Res
. 1995 Nov;
80(4):333-7.
PMID: 8585046
We describe a case of primary amyloidosis (AL) with severe factor X (FX) deficiency in an amateur cyclist presenting with muscular pain at rest and ecchymoses in his legs. No...
10.
Fragasso G, Tresoldi M, Benti R, Vidal M, Marcatti M, Borri A, et al.
Br Heart J
. 1994 Feb;
71(2):166-9.
PMID: 8130026
Background: Immunotherapy with recombinant interleukin 2 (rIL 2) has been extensively used to treat cancer but its use has been hampered by serious side effects including severe hypotension, arrhythmias, and...